ArticleBMC women's health2025
Intimate partner violence exposure among women with psoriasis: a cross-sectional study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntimate partner violence (IPV) exposure is a chronic stressful condition that prevalently affects women’s health and quality of life. As a chronic stressor factor, the presence of IPV and related posttraumatic stress has never been examined in psoriasis patients. The present study aims to evaluate the prevalence of emotional, physical, and sexual IPV exposure, posttraumatic stress symptoms, and quality of life among female psoriasis patients.
methodsThis cross-sectional study included 134 female patients with psoriasis. Disease severity was assessed by a dermatologist using the Psoriasis Area Severity Index (PASI). Patients were asked to complete the Dermatology Life Quality Index (DLQI), the Violence Against Women Instrument (VAWI), and the Posttraumatic Stress Disorder (PTSD) Checklist for DSM-5 (PCL-5).
resultsSixty-two patients (46.3%) were exposed to at least one type of IPV, and psychological IPV (45.5%) was the most prevalent form of IPV. Patients with lifetime IPV exposure had worse dermatological quality of life (U = 1545.00, p = 0.004) and higher posttraumatic stress symptoms (U = 1272.00, p < 0.001). Posttraumatic stress of IPV was related to higher PASI (ρ = 0.184, p = 0.047) and higher DLQI scores (ρ = 0.654, p < 0.001).
conclusionsIPV exposure is a common stressor that influences the psychological health of female psoriasis patients. Lifetime IPV exposure is associated with lower dermatological quality of life and higher posttraumatic stress. Acknowledging IPV-related chronic stress in patients with psoriasis may help increase quality of life. Healthcare providers should be aware of IPV and prevent the deleterious effects of violence on this vulnerable group of women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.